Teoman Dogru

Balikesir, 10145, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study).

Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study).

Journal: Journal of clinical medicine

Published: August 08, 2025

The relationship of circulating MOTS-c level with liver fibrosis and metabolic components in patients with metabolic dysfunction-associated fatty liver disease.

The relationship of circulating MOTS-c level with liver fibrosis and metabolic components in patients with metabolic dysfunction-associated fatty liver disease.

Journal: European review for medical and pharmacological sciences

Published: September 26, 2023

Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease.

Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease.

Journal: Metabolites

Published: May 16, 2021

The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart.

The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart.

Journal: International journal of molecular sciences

Published: May 05, 2021

Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease?

Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease?

Journal: Acta gastro-enterologica Belgica

Published: December 15, 2020

Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease.

Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease.

Journal: Alimentary pharmacology & therapeutics

Published: September 19, 2019

Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease.

Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease.

Journal: European review for medical and pharmacological sciences

Published: November 11, 2016

Betatrophin in nonalcoholic fatty liver disease.

Betatrophin in nonalcoholic fatty liver disease.

Journal: European journal of gastroenterology & hepatology

Published: March 03, 2016

Uric acid in nonalcoholic fatty liver disease.

Uric acid in nonalcoholic fatty liver disease.

Journal: European journal of gastroenterology & hepatology

Published: February 18, 2016

Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease.

Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease.

Journal: European journal of gastroenterology & hepatology

Published: June 11, 2015

The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.

The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.

Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Published: May 30, 2015

Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.

Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.

Journal: Metabolic syndrome and related disorders

Published: May 27, 2015

Showing 1-12 of 28

Last Updated: 09/26/2026